Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alimera Sciences shares fall on UK price setback
Yahoo/AP
Saturday, December 1, 2012 - 9:34am
tags:
Alimera, Iluvien, macular degeneration
Long MannKind's Afrezza: Shares Versus A Bull Call Spread
Seeking Alpha
Saturday, December 1, 2012 - 9:33am
tags:
MannKind, Afrezza, inhaled insulin, diabetes, type 1 diabetes, type 2 diabetes
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, December 1, 2012 - 9:30am
tags:
Acadia, Cadence Pharmaceuticals, Amicus Therapeutics
Buy, Sell, or Hold: Sarepta Therapeutics
Motley Fool
Saturday, December 1, 2012 - 9:28am
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy, muscular dystrophy
Teva provides weak '13 outlook
Yahoo/Investor's Business Daily
Saturday, December 1, 2012 - 9:27am
tags:
Teva Pharmaceuticals
Exelixis' Crowning Achievement
Motley Fool
Saturday, December 1, 2012 - 9:26am
tags:
Exelixis, cabozantinib, Cometriq, thyroid cancer, medullary thyroid cancer
Will Sarepta Receive Accelerated Approval?
Motley Fool
Saturday, December 1, 2012 - 9:25am
tags:
Sarepta, eteplirsen, muscular dystrophy, Duchenne Muscular Dystrophy
Will Merck's Odanacatib Sufficiently Fill Singulair's Void?
Motley Fool
Saturday, December 1, 2012 - 9:23am
tags:
Merck, Odanacatib, osteoporosis
Questcor Pharmaceuticals Inc.: Today's Featured Health Care Laggard
The Street
Saturday, December 1, 2012 - 9:22am
tags:
Questcor Pharmaceuticals
Celgene Corporatio: Today's Featured Drugs Laggard
The Street
Saturday, December 1, 2012 - 9:21am
tags:
Celgene
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Covering
Seeking Alpha
Saturday, December 1, 2012 - 9:19am
tags:
Affymax, Genomic Health, Incyte, Infinity Pharmaceuticals, MAP Pharmaceuticals
Shares Of BioCryst Pop On Merger Termination, But Gains Are Temporary
Seeking Alpha
Friday, November 30, 2012 - 4:02pm
tags:
Biocryst, M&A, Presidio
J&J Wins Reversal of $1.1 Million Levaquin Punitive Award
Bloomberg
Friday, November 30, 2012 - 4:00pm
tags:
JNJ, Levaquin
Celgene, NPS Pharmaceuticals, Amarin, J&J, Medivation Among Stocks to Watch in December
Minyanville
Friday, November 30, 2012 - 12:18pm
tags:
NPS Pharmaceuticals, Medivation, JNJ, Celgene, Amarin
Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013
Seeking Alpha
Friday, November 30, 2012 - 12:17pm
tags:
Aeterna Zentaris, Celsion, OncoSec Medical
Should Congress Probe FDA Over Generic Lipitor?
Pharmalot
Friday, November 30, 2012 - 12:14pm
tags:
FDA, generics, Lipitor, Ranbaxy
3 Top Biopharma Stocks of 2012
Motley Fool
Friday, November 30, 2012 - 12:13pm
tags:
Arena Pharmaceuticals, Celsion, Sarepta Therapeutics
Wall Street Loves Galena Biopharma. Should You?
Motley Fool
Friday, November 30, 2012 - 12:12pm
tags:
Galena Biopharma
Athersys Should Gain At Least 50%
Seeking Alpha
Friday, November 30, 2012 - 12:12pm
tags:
Athersys, stem cells, MultiStem
[video] The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo
TheStreet.com
Friday, November 30, 2012 - 12:11pm
tags:
Biomarin, Sangamo BioSciences, Ligand

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.